Details of the Drug Formulations

General Information of Drug (ID: DMR2J95)

Drug Name

Omadacycline Drug Info

Synonyms

UNII-090IP5RV8F; 090IP5RV8F; Omadacycline [USAN:INN]; Omadacycline (USAN); AC1NUY3H; Amadacycline methanesulfonate; SCHEMBL152

Indication

Disease Entry	ICD 11	Status	REF
Acute bacterial skin infection	1C41	Approved	[1]
Bacterial pneumonia	CA40.0	Approved	[1]
Bacterial infection	1A00-1C4Z	Phase 3	[2]

Cross-matching ID

Full List of Drug Formulations Containing This Drug

Omadacycline 150 mg tablet

Company	Formulation ID	FDA Description
Paratek Pharmaceuticals	F23843	Colloidal Silicon Dioxide; Crospovidone; Glycerol Monocaprylocaprate; Iron Oxide Yellow; Lactose Monohydrate; Microcrystalline Cellulose; Polyvinyl Alcohol; Sodium Bisulfite; Sodium Lauryl Sulfate; Sodium Stearyl Fumarate; Talc; Titanium Dioxide
------------------------------------------------------------------------------------

Omadacycline 100 mg For Injection

Company	Formulation ID	FDA Description
Paratek Pharmaceuticals	F23844	Sucrose; Hydrochloric Acid; Sodium Hydroxide
------------------------------------------------------------------------------------

References

1	Omadacycline Enters the Ring: A New Antimicrobial Contender.Pharmacotherapy. 2018 Dec;38(12):1194-1204.
2	ClinicalTrials.gov (NCT00865280) Study the Safety and Efficacy of PTK 0796 in Patients With Complicated Skin and Skin Structure Infection (CSSSI). U.S. National Institutes of Health.